MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nmd.2019.11.008

Медицинская библиотека · Neuromuscular disorders : NMD · 2019

Paediatric myasthenia gravis: Prognostic factors for drug free remission.

Vecchio Domizia, Ramdas Sithara, Munot Pinki, Pitt Matthew, Beeson David, Knight Ravi, Rodríguez Cruz Pedro, Vincent Angela, Jayawant Sandeep, DeVile Catherine, Buckley Camilla, Hilton-Jones David, Robb Stephanie, Palace Jackie

СтатьяПеревод пока не подготовлен

Аннотация

Our aim was to identify clinical outcomes, serological features and possible prognostic indicators of paediatric myasthenia gravis (MG). We collected 74 MG patients with disease onset before the age of 16 years (73% pre-pubertal onset defined as ≤10 years), seen regularly at two UK specialist centres, over a period of 11 years. The cohort was multi-ethnic, with a high number of non-Caucasians (52%). Ocular presentation was seen in 38 (51%) and only 8 (21%) of these generalised. Fifty-two (70%) patients had antibodies to the acetylcholine receptor (AChR) measured by radioimmunoprecipitation, 10 (14%) had antibodies only to clustered AChRs detected by a cell based assay, 3 (4%) had muscle-specific kinase and one (1%) low-density lipoprotein receptor-related protein 4 antibody. Only 8 (11%) had no detectable antibodies. Seventeen patients attained drug free remission (Kaplan Meyer survival curve estimates 25% by 7 years). Several factors were associated with a higher likelihood of free remission: onset age ≤10 years, Asian and Caucasian races, lack of AChR antibodies on RIA, and normal repetitive nerve stimulation at diagnosis. However, in a multifactorial regression analysis, the antibody status was the only significant predictor for drug free remission, with 60% of patients with antibodies only to clustered AChR achieving this outcome. Complete drug free remission is not uncommon in paediatric MG and several factors appear to influence this outcome with antibody status being the most important. These factors can be easily evaluated at diagnosis, and may help to determine whose patients are likely to require more intensive treatments.

Для цитирования: Vecchio Domizia, Ramdas Sithara, Munot Pinki, Pitt Matthew, Beeson David, Knight Ravi, Rodríguez Cruz Pedro, Vincent Angela, Jayawant Sandeep, DeVile Catherine, Buckley Camilla, Hilton-Jones David, Robb Stephanie, Palace Jackie. Paediatric myasthenia gravis: Prognostic factors for drug free remission.. Neuromuscular disorders : NMD. 2019. DOI: 10.1016/j.nmd.2019.11.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.